Author/Editor | Završnik, Matej | |
Title | Kdaj se odločimo za prehod s peroralne na inzulinsko terapijo? | |
Translated title | When to replace anti-diabetic drugs with insulin therapy? | |
Type | članek | |
Source | Med Razgl | |
Vol. and No. | Letnik 49, št. Suppl 1 | |
Publication year | 2010 | |
Volume | str. 103-8 | |
Language | slo | |
Abstract | Type 2 diabetes is a progresive disease, characterized by the persistent deterioration of the pancreatic endocrinological function manifested with gradually increased glycaemia. As the life expectancy of the general population is on the rise, the life expectancy of patients with type 2 diabetes is also increasing, giving patients time to develop severe insulin deficiency and require insulin replacement. As a result, family physician are treatting more and more patients with type 2 diabetes and they frequently ask themselves When should insulin therapy be initiated? | |
Summary | Sladkorna bolezen tipa 2 je progresivna bolezen z neprestanim poslabševanjem endokrine funkcije trebušne slinavke, kar se kaže v postopnem dvigu glikemije. S podaljševanjem splošne življenjske dobe in še posebno s podaljševanjem življenjske dobe bolnikov s sladkorno boleznijo vse več bolnikov razvije izrazito inzulinsko pomanjkanje ter potrebo po inzulinski terapiji. Družinski zdravniki vodijo vse več bolnikov s sladkorno bolezijo in se pogosto srečujejo s vprašanjem, kdaj uvesti inzulinsko terapijo. | |
Descriptors | HYPOGLYCEMIC AGENTS INSULIN |